Literature DB >> 12123639

Ca(2+) regulation in differentiating lens cells in culture.

Grant C Churchill1, Charles F Louis.   

Abstract

In the ocular lens, cataract formation is associated with an elevated intracellular Ca(2+) concentration (Ca(2+)(i)) resulting from the loss of lens cell Ca(2+) regulation. The mechanisms regulating Ca(2+)(i) have been characterized previously in lens epithelial cells, but have not been well characterized in the more differentiated lens fiber cells. The mechanisms regulating Ca(2+)(i) in clusters of fiber-like cells (lentoids) in a sheep lens primary cell culture system in which the epithelial cells differentiate into enlarged fiber-like cells were investigated. Only approximately 50% of the lentoids responded to thapsigargin and/or agonists (ATP and epinephrine), compared to>95% of the epithelial cells. Remarkably, most (90%) lentoids exhibited a resting cytosolic Ca(2+)(i) that was approximately three-fold greater than that in epithelial cells (approximately 100n M). This elevated resting cytosolic Ca(2+)(i) was not affected by thapsigargin treatment, but decreased upon removal of extracellular Ca(2+) or addition of the Ca(2+) channel blocker Gd(3+) (5mM ). These results suggest that a plasma membrane Ca(2+) channel is more active in lentoids than in epithelial cells. Indeed, when plasma membrane cation channel activity was monitored by Mn(2+) influx and quenching of fura-2 fluorescence, quenching was faster in lentoids than epithelial cells. Following thapsigargin treatment, capacitative Ca(2+) entry was activated in epithelial cells but not lentoids. In conclusion, during differentiation in primary cell culture, lens cells lose their ability to respond to agonists and exhibit an elevated resting Ca(2+)(i) that was dependent on the activation of a Ca(2+) influx pathway. The results of this study support the possibility that a sustained elevation in resting Ca(2+)(i) is one of the factors controlling lens cell differentiation, possibly by triggering events such as calpain activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123639     DOI: 10.1006/exer.2002.1184

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

Review 1.  Lens fibre cell differentiation and organelle loss: many paths lead to clarity.

Authors:  Michael A Wride
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-04-27       Impact factor: 6.237

2.  Abnormal bradykinin signalling in fibroblasts deficient in the PIP(2) 5-phosphatase, ocrl1.

Authors:  S F Suchy; J C Cronin; R L Nussbaum
Journal:  J Inherit Metab Dis       Date:  2009-01-28       Impact factor: 4.982

3.  Differential membrane redistribution of P2X receptor isoforms in response to osmotic and hyperglycemic stress in the rat lens.

Authors:  Haruna Suzuki-Kerr; Julie C Lim; Srdjan M Vlajkovic; Paul J Donaldson
Journal:  Histochem Cell Biol       Date:  2009-03-14       Impact factor: 4.304

4.  Expression of TGF-beta2 mRNA and PCNA, FN protein in lens epithelial cells in age-related nuclear and cortex cataract.

Authors:  Lin Ye; Qin Li; Xiaojun Cai; Ping Deng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

5.  Cataract Progression Associated with Modifications in Calcium Signaling in Human Lens Epithelia as Studied by Mechanical Stimulation.

Authors:  Marko Gosak; Dajana Gojić; Elena Spasovska; Marko Hawlina; Sofija Andjelic
Journal:  Life (Basel)       Date:  2021-04-21

6.  Downregulation of SMP30 in senescent human lens epithelial cells.

Authors:  Shuning Li; Xi Chen; Weixia Lai; Meixia Hu; Xin Zhong; Shaojian Tan; Hao Liang
Journal:  Mol Med Rep       Date:  2017-07-27       Impact factor: 2.952

7.  Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification.

Authors:  Tertius A Hough; Debora Bogani; Michael T Cheeseman; Jack Favor; M Andrew Nesbit; Rajesh V Thakker; Mary F Lyon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-03       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.